ESC Premium Access

Aortic valve hemodynamic deterioration after transcatheter aortic valve implantation (TAVI) and its association with anti-thrombotic therapy.

Congress Presentation

About the speaker

Doctor Claudio Guerreiro

Hospital Center of Vila Nova de Gaia/Espinho, Vila Nova de Gaia (Portugal)
0 follower

10 more presentations in this session

Outcomes in a resource-constrained economy: results from the multi-centre South African SHARE-TAVI registry

Speaker: Doctor H. Weich (Cape Town, ZA)

Thumbnail

Risk factors and outcome of postoperative delirium after transcatheter aortic valve replacement

Speaker: Doctor P. Stachon (Freiburg, DE)

Thumbnail

Impact of reduced left ventricular ejection fraction on outcomes after transcatheter aortic valve implantation

Speaker: Doctor A. Munoz Garcia (Malaga, ES)

Thumbnail

Prognostic value of heart failure before and during the first year after TAVI. Factors determining heart failure after TAVI.

Speaker: Miss R. GONZALEZ FERREIRO (Vigo, ES)

Thumbnail

Incidence, predictive and prognostic factors of hospitalization for cardiac heart failure in patients implanted with TAVR

Speaker: Professor E. Durand (Rouen, FR)

Thumbnail

Access the full session

Poster session 5 - Trans-catheter valve interventions and their complications

Speakers: Doctor C. Guerreiro, Doctor H. Weich, Doctor P. Stachon, Doctor A. Munoz Garcia, Miss R. GONZALEZ FERREIRO...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb